Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience
Margaret E Heffernan, Suzanne M Garland, Mark A Kane
Sexual Health | CSIRO PUBLISHING | Published : 2010
MEH has received travel support from CSL and GlaxoSmithKline (GSK) to attend two international HPV conferences. SMG has received advisory board fees and grant support from CSL and GSK, and lecture fees from Merck and GSK; in addition, she has received funding through her institution to conduct HPV vaccine studies for MSD and GSK. SMG is a member of the Merck Global Advisory Board as well as of the Merck Scientific Advisory Committee for HPV. MK is on the Merck Global Advisory Board for HPV and has received honoraria for speaking from both Merck and GSK.